Riken Pharmaceuticals Pvt. Ltd

Riken Pharmaceuticals Pvt. Ltd Riken Pharmaceuticals began in 2012 delivering innovative, cast effective and high-quality medicines

Today, Riken Pharmaceuticals ranks among the top fastest growing pharmaceutical companies in India by virtue of strategic alliances, synergetic acquisitions and above all an extensive marketing and distribution network. Currently Riken Pharmaceuticals operates through 2 therapy focused marketing divisions, each with an independent field force. Our business in India started with launch of Cobapin,

Hitfer XT, Tussfit, Razofit, Fitcold, Moxken CV, Podwin, Ofken and Kitmol. Our market penetration through sales force that connect to the maximum doctors on a regular basis has yielded us reaching all corners of the country and providing affordable and innovative medicines in all major therapeutic areas like Gastro-intestinal, Anti-Infective, Respiratory, Nutraceuticals, Pain management, Cardiovascular, Dermatology, Diabetes, etc. Alongside the presence of end-to-end pharmaceutical capabilities within the organization helps us to cater customer and patient as per there need much more effectively.

शुभं करोति कल्याणम् आरोग्यम् धनसंपदा ।शत्रुबुद्धिविनाशाय दीपज्योति नमोऽस्तुते ॥ *"शुभ दीपावली"*
12/11/2023

शुभं करोति कल्याणम् आरोग्यम् धनसंपदा ।
शत्रुबुद्धिविनाशाय दीपज्योति नमोऽस्तुते ॥

*"शुभ दीपावली"*

16/10/2021

Products promotion to the doctor and chemist.

15/08/2021
01/07/2021

Medicine products promotion to the doctor and chemist to achieve monthly sales target.

24/07/2019

Product promotion to doctors and chemists

Tooth loss or missing teeth due to decay or periodontal disease may suggest an increased risk of type 2 diabetes (T2D), ...
19/05/2018

Tooth loss or missing teeth due to decay or periodontal disease may suggest an increased risk of type 2 diabetes (T2D), according to a study presented at ENDO 2018 held in Chicago, Illinois, US. Dental caries and periodontal disease are hallmarks of poor dental health which, if left untreated, may lead to tooth loss,said lead author Dr Raynald Samoa from the Department of Diabetes, Endocrinology & Metabolism at the City of Hope National Medical Center in Duarte, California, US.“Ourresults showed a progressive positive relationship between worsening glucose tolerance and number of missing teeth.”Samoa and colleagues established the link between dental health and glucose toleranceby reviewing records of 9,670 adults (>20 years) and evaluating the following parameters: body mass index (BMI) and glucose tolerance states by fasting plasma glucose, 2-hour post-challenge plasma glucose, HbA1c, established T2D, and treatment with oral agents or insulin. Participants were divided into three groups according to glucose tolerance (GT): normal (NGT), abnormal (AGT), or T2D. Dental records were documented to determine the number of decayed or missing teeth caused by caries or periodontal disease and periodontal status. [ENDO 2018, abstractMON-118]The incidence of missing teeth was highest among those with reduced glucose tolerance (45.57 percent, 67.61 percent, and82.87 percent in the NGT, AGT, and T2D groups, respectively; p

Address

Delhi
110032

Website

Alerts

Be the first to know and let us send you an email when Riken Pharmaceuticals Pvt. Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Riken Pharmaceuticals Pvt. Ltd:

Shortcuts

Share

Category